BRPI0314120B8 - processo para diminuição de um nível de agregado de um antagonista de hormônio do crescimento (gh) peguilado e isoformas do mesmo - Google Patents

processo para diminuição de um nível de agregado de um antagonista de hormônio do crescimento (gh) peguilado e isoformas do mesmo

Info

Publication number
BRPI0314120B8
BRPI0314120B8 BRPI0314120A BR0314120A BRPI0314120B8 BR PI0314120 B8 BRPI0314120 B8 BR PI0314120B8 BR PI0314120 A BRPI0314120 A BR PI0314120A BR 0314120 A BR0314120 A BR 0314120A BR PI0314120 B8 BRPI0314120 B8 BR PI0314120B8
Authority
BR
Brazil
Prior art keywords
isoforms
antagonist
decreasing
growth hormone
aggregate level
Prior art date
Application number
BRPI0314120A
Other languages
English (en)
Other versions
BR0314120A (pt
BRPI0314120B1 (pt
Inventor
S Rathore Anurag
E Steinmeyer David
M Boyle Denis
V Johnson Gary
j buckley John
Toal Michele
Aykent Serdar
Original Assignee
Pharmacia Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/646,798 external-priority patent/US20040048315A1/en
Application filed by Pharmacia Corp filed Critical Pharmacia Corp
Publication of BR0314120A publication Critical patent/BR0314120A/pt
Publication of BRPI0314120B1 publication Critical patent/BRPI0314120B1/pt
Publication of BRPI0314120B8 publication Critical patent/BRPI0314120B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormones [GH] (Somatotropin)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/18—Ion-exchange chromatography
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/30—Extraction; Separation; Purification by precipitation
    • C07K1/32—Extraction; Separation; Purification by precipitation as complexes

Abstract

processo para a diminuição dos níveis de agregado de proteína peguilada. a presente invenção refere-se a métodos recombinantes para fabricação de uma proteína peguilada desejada e agrupamento da mesma. esse(s) método(s) fornece(m) um produto de polipeptídeo contendo níveis reduzidos de seu agregado agrupado para prover as suas isoformas peguiladas desejadas.
BRPI0314120A 2002-09-20 2003-09-22 processo para diminuição de um nível de agregado de um antagonista de hormônio do crescimento (gh) peguilado e isoformas do mesmo BRPI0314120B8 (pt)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US41222702P 2002-09-20 2002-09-20
US60/412,227 2002-09-20
US10/646,798 2003-08-25
US10/646,798 US20040048315A1 (en) 2002-08-28 2003-08-25 Method for the preparation of growth hormone and antagonist thereof having lower levels of isoform impurities thereof
US66288403A 2003-09-16 2003-09-16
US10/662,884 2003-09-16
PCT/US2003/029546 WO2004026251A2 (en) 2002-09-20 2003-09-22 Process for decreasing aggregate levels of pegylated protein

Publications (3)

Publication Number Publication Date
BR0314120A BR0314120A (pt) 2005-07-12
BRPI0314120B1 BRPI0314120B1 (pt) 2020-12-29
BRPI0314120B8 true BRPI0314120B8 (pt) 2021-05-25

Family

ID=32034217

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0314120A BRPI0314120B8 (pt) 2002-09-20 2003-09-22 processo para diminuição de um nível de agregado de um antagonista de hormônio do crescimento (gh) peguilado e isoformas do mesmo

Country Status (17)

Country Link
EP (1) EP1545428B1 (pt)
JP (1) JP4633463B2 (pt)
KR (1) KR101120130B1 (pt)
AT (1) ATE453662T1 (pt)
AU (1) AU2003272585B2 (pt)
BR (1) BRPI0314120B8 (pt)
CA (1) CA2498886C (pt)
DE (1) DE60330787D1 (pt)
DK (1) DK1545428T3 (pt)
ES (1) ES2337041T3 (pt)
HK (1) HK1079798B (pt)
IL (1) IL167538A (pt)
MX (1) MXPA05003121A (pt)
PL (1) PL212726B1 (pt)
PT (1) PT1545428E (pt)
SI (1) SI1545428T1 (pt)
WO (1) WO2004026251A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007522198A (ja) * 2004-02-09 2007-08-09 ファルマシア コーポレーション 化学修飾されたヒト成長ホルモン受容体アンタゴニスト結合体
EP1836316A4 (en) * 2004-12-22 2009-07-22 Ambrx Inc PROCESS FOR EXPRESSION AND CLEANING OF RECOMBINANT HUMAN GROWTH HORMONE
WO2011018515A1 (en) * 2009-08-14 2011-02-17 Novo Nordisk Health Care Ag Method of purifying pegylated proteins
US9562252B2 (en) * 2011-05-13 2017-02-07 Biogen Ma Inc. Methods of preventing and removing trisulfide bonds
KR20140062044A (ko) 2011-08-25 2014-05-22 에프. 호프만-라 로슈 아게 양이온 및 음이온 교환 크로마토그래피 방법
WO2019129877A1 (en) * 2017-12-29 2019-07-04 F. Hoffmann-La Roche Ag Process for providing pegylated protein composition
CN112107880B (zh) * 2020-09-16 2022-08-09 珠海中科先进技术研究院有限公司 一种低共熔混合物及利用其萃取鲟鱼鱼籽蛋白质的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5153265A (en) * 1988-01-20 1992-10-06 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US4847325A (en) * 1988-01-20 1989-07-11 Cetus Corporation Conjugation of polymer to colony stimulating factor-1
US5969109A (en) * 1990-02-28 1999-10-19 Bona; Constantin Chimeric antibodies comprising antigen binding sites and B and T cell epitopes
DK44593D0 (da) * 1993-04-20 1993-04-20 Novo Nordisk As Fremgangsmaade til fremstilling af et polypeptid
ZA955789B (en) * 1994-07-15 1996-03-11 Novo Nordisk As A method of converting a hydrophobic derivative of a polypeptide into the native form
WO1996040731A1 (en) * 1995-06-07 1996-12-19 Mount Sinai School Of Medicine Of The City University Of New York Pegylated modified proteins
ATE455171T1 (de) * 1995-09-21 2010-01-15 Genentech Inc Varianten des menschlichen wachstumshormons
SE9802454D0 (sv) * 1998-07-08 1998-07-08 Pharmacia & Upjohn Ab Production of peptides
SE9904502D0 (sv) * 1999-12-09 1999-12-09 Pharmacia & Upjohn Ab Production of peptides

Also Published As

Publication number Publication date
ATE453662T1 (de) 2010-01-15
JP4633463B2 (ja) 2011-02-16
KR20050046011A (ko) 2005-05-17
PL212726B1 (pl) 2012-11-30
PT1545428E (pt) 2010-02-25
CA2498886C (en) 2013-06-25
AU2003272585A1 (en) 2004-04-08
MXPA05003121A (es) 2005-06-22
WO2004026251A3 (en) 2004-09-02
EP1545428B1 (en) 2009-12-30
IL167538A (en) 2015-10-29
HK1079798B (zh) 2010-11-19
EP1545428A4 (en) 2006-03-01
DE60330787D1 (de) 2010-02-11
KR101120130B1 (ko) 2012-04-18
BR0314120A (pt) 2005-07-12
CA2498886A1 (en) 2004-04-01
JP2006516021A (ja) 2006-06-15
WO2004026251A2 (en) 2004-04-01
ES2337041T3 (es) 2010-04-20
SI1545428T1 (sl) 2010-03-31
PL375443A1 (en) 2005-11-28
HK1079798A1 (en) 2006-04-13
EP1545428A2 (en) 2005-06-29
AU2003272585B2 (en) 2009-12-10
BRPI0314120B1 (pt) 2020-12-29
DK1545428T3 (da) 2010-05-03

Similar Documents

Publication Publication Date Title
IL167538A (en) A process for reducing the level of the pegilated growth hormone antibody aggregate
HK1067128A1 (en) Beta-carbolin derivatives as ptp-inhibitors
CY1109167T1 (el) Μεθοδος για την παρασκευη αυξητικης ορμονης και ανταγωνιστη αυτης εχοντας χαμηλοτερα επιπεδα ισομορφικων προσμειξεων αυτου
BRPI0410164A (pt) composições e métodos para preparação de mutantes de glicosilação de hormÈnio do crescimento humano
WO1998024804A3 (en) INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
DE69729125D1 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ATE426024T1 (de) C-c chemokin rezeptor 3: ckr-3 oder eos-l2
Pes et al. Odorant-binding proteins of the mouse
AU2002328429A1 (en) CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
HUP0200079A2 (hu) A terméketlenség kezelése
Sharma et al. Implantation Serine Proteinases heterodimerize and are critical in hatching and implantation
JP2002527062A (ja) 活性なβ−ＮＧＦを得るための方法
ATE464320T1 (de) Ntb-a, ein oberflächenmolekül impliziert in der aktivität natürlicher killerzellen (nk)
Nallaseth et al. The role of basic amino acid surface clusters on the collagenase activity of cathepsin K
TW200502248A (en) Process for decreasing aggregate levels of pegylated protein
ATE439600T1 (de) Verfahren zur charakterisierung der glycosilierung von sialoglycoproteinen über eine isoformenzahl i
Sang et al. Collagenase 4
PL335459A1 (en) Aminopeptidaze obtained from bacillus licheniformis and process for obtaining proteins of natural type
Toomim et al. Thiol and aspartyl proteolytic activities in secretory vesicles of bovine pituitary
WO2003040343A3 (en) Polynucleotide and polypeptide sequences of canine cathepsin s
BR0210870A (pt) Aminopeptidase derivada de bacillus licheniformis, gene codificando a aminopeptidase vetor de expressão contendo o gene, transformante e método para preparação destes
WO2003074562A3 (en) Vanilloid receptor (trpv) fusion proteins
KR20030085337A (ko) 인간 유래의 ｂｍｐ-2 단백질 발현벡터 및 이를 이용한ｂｍｐ-2 대량 생산방법
EP0641858A4 (en) DEPRESSOR FACTOR FOR CALCIUM SERUM CONTENT.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/12/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/09/2003 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF